Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
Physiology of serum free light chains - Renal Fellow Network
Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers – topic of research paper in Biological sciences. Download scholarly article PDF and read
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Correspondence data for kappa and lambda free light chain analysis | Download Table
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy | PLOS ONE
Serum Free Light Chains and the Risk of ESRD and Death in CKD Article
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table4-1.png "PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar")
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
JCM | Free Full-Text | Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/2-Table1-1.png "PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar")
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Comparison of Free Light Chain Removal by Four Blood Purification Methods - Kanayama - 2011 - Therapeutic Apheresis and Dialysis - Wiley Online Library
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
Serum Free Light Chain Assay - Renal Fellow Network
View Image
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
Curing Cast Nephropathy by Removing Not-so-light Chains? — NephJC
